FindTrial
Sign In

Zinc supplementation in Celiac Disease

EFFICACY OF ORAL ZINC SUPPLEMENTATION IN CHILDREN WITH CELIAC DISEASE: A PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL - EZSCCD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038310
Enrollment
136
Registered
2021-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K639- Disease of intestine, unspecified

Interventions

Intervention1: Zinc: 20 mg of Zinc per day for 4 weeks Control Intervention1: Placebo: 5 ml of placebo per day for 4 weeks

Sponsors

Chacha Nehru Bal Chikitsalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: New diagnosed celiac disease patients

Exclusion criteria

Exclusion criteria: On GFD before diagnosis of celiac disease, received zinc in last three months for 2 weeks,not willing for follow up at 4 weeks

Design outcomes

Primary

MeasureTime frame
To compare serum zinc levels in children with celiac disease receiving four weeks of oral zinc supplementation in addition to gluten free diet versus those treated with placebo and gluten free diet. Timepoint: 4 weeks after initiation of GFD—

Secondary

MeasureTime frame
TGA-IgA antibody between the two groups at 4 weeks Weight between the two groups at 4 weeks Hb between the two groups at 4 weeks Timepoint: 4 weeks—

Countries

India

Contacts

Public ContactHarini Bandarpalli

Chacha Nehru Bal Chikitsalaya

anuradharai2@gmail.com8800674851

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026